Digital Ischemic Loss in Systemic Sclerosis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Likely</td><td align="left">Possible</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Diffuse cutaneous subtype</td><td align="left" rowspan="5">Anti-topoisomerase antibodies</td></tr><tr><td align="left">Anti-centromere antibodies</td></tr><tr><td align="left">Current smoking</td></tr><tr><td align="left">Anti-beta2-glycoprotein I antibodies</td></tr><tr><td align="left">Anti-granzyme B antibodies</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Potential risk factors for digital ischemic loss in patients with systemic sclerosis.

International Journal of Rheumatology

tab1

Table 1

Table 1: Digital Ischemic Loss in Systemic Sclerosis 